Clostridioides difficile

How Have FDA Approvals Changed the Landscape of Microbiome Therapeutics?

At DDW 2024, Jessica Allegretti, MD, MPH, described new treatments for recurrent C. difficile and how she ...

AUGUST 19, 2024

The Time Is Right to Study Microbiome in IBD Therapy

Fecal microbiota transplants that alter the gut microbiome could bring relief to people with IBD who do not respond ...

JUNE 18, 2024

C. diff Update: Tips to Treat a Stubborn Infection

Managing Clostridioides difficile infection is a challenge that requires a multipronged approach.

APRIL 19, 2024

Gut Microbiome Updates From ACG 2023

The microbiome topics at ACG 2023 covered almost every organ system and did not disappoint with interesting ...

JANUARY 14, 2024

Study Underscores Need to Evaluate for Liver Disease in Patients With C. diff

Patients with Clostridioides difficile infections who also have metabolic–dysfunction associated ...

DECEMBER 17, 2023

A New Era for Managing Clostridioides difficile Infection

We have started to understand the critical components of the gut microbiome that prevent C. difficile expansion, ...

OCTOBER 17, 2023

Elena Ivanina, DO, MPH, on Incorporating Holistic Care Into Practice

Dr. Ivanina sat down with GEN’s Sarah Tilyou to discuss how the microbiome comes into play in her practice ...

OCTOBER 6, 2023

2 Steps Are Better Than 1 for CDI Testing

A two-step algorithm for Clostridioides difficile infection testing may reduce unnecessary treatment and improve ...

JUNE 12, 2023

FDA Approves Rebyota, the First Live Biotherapeutic Fecal Microbiota Product in the U.S.

RBX2660 (Rebyota, Ferring) is approved by the FDA for the prevention of recurrent Clostridioides difficile ...

DECEMBER 5, 2022

Recently Hospitalized Patients Increase Risk for Household Transmission of CDI

Exposure to recently hospitalized family members significantly increased the risk for developing C. difficile ...

JUNE 2, 2022

Increased C. difficile Risk for Patients in Rooms Previously Occupied by CDI-Infected Patients

A hospitalized patient whose room was previously occupied by someone with CDI is 27% more likely to become infected ...

MAY 27, 2022

C. difficile Common in Brazilian ICUs, but Not Linked to Diarrhea or Mortality

Brazilian researchers at two tertiary care hospitals found 17% of a group of 92 adult ICU patients were colonized ...

APRIL 19, 2022

Load more